Outcomes of patients with POEMS syndrome treated initially with radiation

Blood

Volumn 122, Issue 1, 2013, Pages 68-73

  Humeniuk, Michael S ^a   Gertz, Morie A ^a   Lacy, Martha Q ^a   Kyle, Robert A ^a   Witzig, Thomas E ^a   Kumar, Shaji K ^a   Kapoor, Prashant ^a   Lust, John A ^a   Hayman, Suzanne R ^a   Buadi, Francis K ^a   Rajkumar, S Vincent ^a   Zeldenrust, Steven R ^a   Russell, Stephen J ^a   Dingli, David ^a   Lin, Yi ^a   Leung, Nelson ^a   Dispenzieri, Angela ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; FLUORODEOXYGLUCOSE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAIN; VASCULOTROPIN; CORTICOSTEROID; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BONE LESION; BONE MARROW BIOPSY; CLINICAL ARTICLE; DISABILITY; EDEMA; EMISSION TOMOGRAPHY; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LUNG DIFFUSION CAPACITY; LYMPHADENOPATHY; MALE; NEUROPATHY; OVERALL SURVIVAL; PAPILLEDEMA; POEMS SYNDROME; POSITRON; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RADIATION DOSE; RADIOTHERAPY; RELAPSE; RISK FACTOR; SALVAGE THERAPY; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE; CHEMORADIOTHERAPY; DISEASE FREE SURVIVAL; FACTUAL DATABASE; METABOLISM; METHODOLOGY; MIDDLE AGED; MORTALITY; REMISSION; RETROSPECTIVE STUDY; STEM CELL MOBILIZATION; VERY ELDERLY;

ADRENAL CORTEX HORMONES; ADULT; AGED; AGED, 80 AND OVER; CHEMORADIOTHERAPY; DATABASES, FACTUAL; DISEASE-FREE SURVIVAL; FEMALE; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; MALE; MIDDLE AGED; POEMS SYNDROME; RADIOTHERAPY; REMISSION INDUCTION; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 84883712887     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-03-487025     Document Type: Article

References (24)

1. Dispenzieri A. POEMS syndrome: 2011 update on diagnosis, risk-stratification, and management. Am J Hematol. 2011;86(7):591-601.
2. Royer B, Merlusca L, Abraham J, et al. Efficacy of lenalidomide in POEMS syndrome: a retrospective study of 20 patients. Am J Hematol. 2013;88(3):207-212.
3. Li J, Zhang W, Jiao L, et al. Combination of melphalan and dexamethasone for patients with newly diagnosed POEMS syndrome [published online ahead of print March 12, 2011]. Blood. 2011;117(24):6445-6449.
4. Soutar R, Lucraft H, Jackson G, Reece A, Bird J, Low E, Samson D; Working Group of the UK Myeloma Forum; British Committee for Standards in Haematology; British Society for Haematology. Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma. Clin Oncol (R Coll Radiol). 2004;16(6):405-413. (Pubitemid 39186145)
5. Liebross RH, Ha CS, Cox JD, Weber D, Delasalle K, Alexanian R. Solitary bone plasmacytoma: outcome and prognostic factors following radiotherapy. Int J Radiat Oncol Biol Phys. 1998; 41(5):1063-1067. (Pubitemid 28377487)
6. Dispenzieri A, Kyle RA, Lacy MQ, et al. POEMS syndrome: definitions and long-term outcome [published online ahead of print November 29, 2002]. Blood. 2003;101(7):2496-2506. (Pubitemid 36857604)
7. Morley JB, Schwieger AC. The relation between chronic polyneuropathy and osteosclerotic myeloma. J Neurol Neurosurg Psychiatry. 1967; 30(5):432-442.
8. Davis LE, Drachman DB. Myeloma neuropathy. Successful treatment of two patients and review of cases. Arch Neurol. 1972;27(6):507-511.
9. Reitan JB, Pape E, Fosså SD, Julsrud OJ, Slettnes ON, Solheim OP. Osteosclerotic myeloma with polyneuropathy. Acta Med Scand. 1980;208(1-2):137- 144. (Pubitemid 10004178)
10. Iwashita H, Ohnishi A, Asada M, Kanazawa Y, Kuroiwa Y. Polyneuropathy, skin hyperpigmentation, edema, and hypertrichosis in localized osteosclerotic myeloma. Neurology. 1977;27(7):675-681. (Pubitemid 8145798)
11. Shibuya K, Misawa S, Horikoshi T, et al. Detection of bone lesions by CT in POEMS syndrome. Intern Med. 2011;50(13):1393-1396.
12. D'Souza A, Lacy M, Gertz M, et al. Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a singlecenter experience [published online ahead of print May 23, 2012]. Blood. 2012;120(1):56-62.
13. Kyle RA, Rajkumar SV. Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma. Leukemia. 2009;23(1):3-9.
14. Durie BG, Harousseau JL, Miguel JS, et al. International uniform response criteria for multiple myeloma. Leukemia. Leukemia. 2006;20(9): 1467-1473. (Pubitemid 44264086)
15. Dimopoulos MA, Moulopoulos LA, Maniatis A, Alexanian R. Solitary plasmacytoma of bone and asymptomatic multiple myeloma . Blood. 2000; 96(6):2037-2044.
16. Mill WB. Radiation therapy in multiple myeloma. Radiology. 1975;115(1):175-178.
17. Frassica DA, Frassica FJ, Schray MF, Sim FH, Kyle RA. Solitary plasmacytoma of bone: Mayo Clinic experience. Int J Radiat Oncol Biol. 1989;16(1):43-48. (Pubitemid 19045333)
18. Suh YG, Suh CO, Kim JS, Kim SJ, Pyun HO, Cho J. Radiotherapy for solitary plasmacytoma of bone and soft tissue: outcomes and prognostic factors. Ann Hematol. 2012;91(11): 1785-1793.
19. Ozsahin M, Tsang RW, Poortmans P, et al. Outcomes and patterns of failure in solitary plasmacytoma: a multicenter Rare Cancer Network study of 258 patients. Int J Radiat Oncol Biol Phys. 2006;64(1):210-217. (Pubitemid 41831229)
20. Bolek TW, Marcus RB Jr, Mendenhall NP. Solitary plasmacytoma of bone and soft tissue. Int J Radiat Oncol Biol Phys. 1996;36(2): 329-333. (Pubitemid 26359457)
21. Dingli D, Kyle RA, Rajkumar SV, et al. Immunoglobulin free light chains and solitary plasmacytoma of bone [published online ahead of print June 3, 2006]. Blood. 2006;108(6): 1979-1983. (Pubitemid 44395010)
22. Knobel D, Zouhair A, Tsang RW, et al. Prognostic factors in solitary plasmacytoma of the bone: a multicenter Rare Cancer Network study. BMC Cancer. 2006;6:118.
23. Warsame R, Gertz MA, Lacy MQ, et al. Trends and outcomes of modern staging of solitary plasmacytoma of bone. Am J Hematol. 2012; 87(7):647-651.
24. Imai N, Taguchi J, Yagi N, Konishi T, Serizawa M, Kobari M. Relapse of polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes (POEMS) syndrome without increased level of vascular endothelial growth factor following successful autologous peripheral blood stem cell transplantation. Neuromuscul Disord. 2009;19(5): 363-365.